Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

JS Genetics LLC
Profile last edited on: 6/19/19      CAGE: 47XT7      UEI:

Business Identifier: Genetic diagnostic tests for the pediatric market
Year Founded
2004
First Award
2006
Latest Award
2011
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

2 Church Street South Suite B-05b
New Haven, CT 06519
   (203) 624-5742
   info@jsgenetics.com
   www.jsgenetics.com
Location: Multiple
Congr. District: 03
County: New Haven

Public Profile

JS Genetics LLC, spun out of Yale University Medical School laboratories, develops and markets accurate, convenient and cost effective DNA diagnostic tests for underserved medical conditions in newborns and adolescents. The DNA tests are done using a pyrosequencing-based approach and are focused on three key areas of developmental disorders: Physical Development tests (Turner Syndrome, Klinefelter Syndrome & Down’s Syndrome), Cogneitive Development tests (Dyslexia & Klinefelter Syndrome) and Behavioral Development tests (Fragile X Syndrome & Klinefelter Syndrome).

Extent of SBIR involvement

User Avatar
Phase I Awards
4
Phase II Awards
3
Conversion Rate
75.00%
Phase I Dollars
$520,671
Phase II Dollars
$2,670,432
Total Awarded
$3,191,103

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2011 2 NIH $859,089
Project Title: Identification Of Oligodendrocyte Stimulators
2011 2 NIH $1,187,500
Project Title: Development Of Novel Diagnostics For Fragile X Syndrome
2008 2 NIH $1,022,350
Project Title: Newborn Screening for Sex Chromosome Disorders
2007 1 NIH $122,164
Project Title: Molecular Diagnosis of Dyslexia

Key People / Management

  Alidad Mireskandari -- Chief Executive Officer; President

  Richard Champagne

  Karl Hager -- Senior Scientist

  Seiyu Hosono -- Vice President of Research and Development

  Scott A Rivkees -- Co-Founder; Scientific Advisor

  Tom Sinnamon -- Vice President of Sales & Marketing,

Company News

There are no news available.